Redwood City, CA30+ days ago
DBTx leverages state of the art technologies, complemented by deep subject matter expertise and broad scientific knowledge, to deliver innovative and comprehensive preclinical in vitro datasets to support our drug discovery pipeline in disease areas such as oncology, immunology, neuroscience and cell therapy. + Advance screening technology for various antibody and CAR formats (bi-specifics, ADCs, AOCs, TCEs, CARs) with an emphasis on patho-physiologically relevant cellular models, including co-cultures, organoids, human derived iPSC, primary cells, micropatterned 2D culture, tissue-on-a-chip, or other 3D models.